| Endocrine Carcinoma altered in cohorts of …ALTERED_INderived200 of 254show all (up to 200) |
|---|
| ← altered in cohorts of | POLE 20 / 20 cases (100 %) · ssm · sclc_cancercell_gardner_2017 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 103 / 120 cases (86 %) · ssm · sclc_ucologne_2015 · largest of 3 cohorts | — | — | Lung Small Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1 71 / 92 cases (77 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AVPR1A 70 / 92 cases (76 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BAZ2A 70 / 92 cases (76 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CAND1 70 / 92 cases (76 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HSD17B6 70 / 92 cases (76 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NACA 70 / 92 cases (76 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AGAP2 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP23 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP5F1B 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AVIL 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BIN2 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDK4 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CTDSP2 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP27B1 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DYRK2 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EEF1AKMT3 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FRS2 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL22 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MARCHF9 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | METTL1 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OS9 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRIM1 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTGES3 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBMS2 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STAT6 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TSFM 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TSPAN31 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBTB39 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD52 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARHGAP9 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARHGEF25 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | B4GALNT1 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BEST3 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C12orf66 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CELA1 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CPM 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSRNP2 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DCTN2 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DDIT3 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DPY19L2 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DTX3 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ERBB3 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ESYT1 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GLI1 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GLS2 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GNS 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR182 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GRIP1 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HDAC7 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HIGD1C 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL26 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INHBC 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INHBE 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIF5A 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KRT74 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KRT75 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KRT84 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LETMD1 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LGR5 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC10 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC43 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MDM2 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | METTL7A 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MSRB3 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYO1A 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NAB2 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NDUFA4L2 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NEMP1 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NUP107 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NXPH4 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCED1B 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIP4K2C 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POU6F1 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAB3IP 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAP1B 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RDH16 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL41 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RXYLT1 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCN8A 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHMT2 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC11A2 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC35E3 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMAGP 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPRYD4 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SRGAP1 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STAC3 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SUOX 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TAC3 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TFCP2 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | XPOT 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | YEATS4 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZC3H10 68 / 92 cases (74 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RB1 87 / 120 cases (73 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 77 / 120 cases (64 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRAF 293 / 496 cases (59 %) · ssm · thpa_tcga_gdc · largest of 4 cohorts | — | — | Thyroid Gland Papillary Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFPM1 47 / 90 cases (52 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 54 / 120 cases (45 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 51 / 120 cases (43 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 49 / 120 cases (41 %) · ssm · sclc_ucologne_2015 · largest of 2 cohorts | — | — | Lung Small Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5B 35 / 90 cases (39 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX4 46 / 120 cases (38 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GARS1 34 / 90 cases (38 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 44 / 120 cases (37 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF517 33 / 90 cases (37 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 42 / 120 cases (35 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRIG1 31 / 90 cases (34 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC2 28 / 90 cases (31 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LACTB 27 / 90 cases (30 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 27 / 90 cases (30 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NAV3 35 / 120 cases (29 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CCDC102A 26 / 90 cases (29 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OPRD1 26 / 90 cases (29 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SOWAHA 26 / 90 cases (29 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TOR3A 25 / 90 cases (28 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USP42 25 / 90 cases (28 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CRIPAK 24 / 90 cases (27 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH15 32 / 120 cases (27 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PODXL 24 / 90 cases (27 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF787 24 / 90 cases (27 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OR11H12 104 / 394 cases (26 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL11A1 31 / 120 cases (26 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRIOBP 23 / 90 cases (26 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAM243B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNE1B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMIM11B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMIM34B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR11H1 98 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAL2 22 / 90 cases (24 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | POTEH 96 / 394 cases (24 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSMD1 28 / 120 cases (23 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IRX3 21 / 90 cases (23 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC4 21 / 90 cases (23 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TPO 21 / 90 cases (23 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTNAP3C 89 / 394 cases (23 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A7 89 / 394 cases (23 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EYS 27 / 120 cases (23 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 27 / 120 cases (23 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 27 / 120 cases (23 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPATA31A5 88 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM247 20 / 90 cases (22 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FOXD4L5 87 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD30B 26 / 120 cases (22 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAM135B 26 / 120 cases (22 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANKRD20A4P 85 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CBWD5 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXD4L4 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEM 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FSIP2 25 / 120 cases (21 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TMEM132D 25 / 120 cases (21 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANKRD20A3P 79 / 394 cases (20 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ERICH3 24 / 120 cases (20 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1 24 / 120 cases (20 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SI 24 / 120 cases (20 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF658 77 / 394 cases (20 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A3 76 / 394 cases (19 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PKHD1L1 23 / 120 cases (19 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 23 / 120 cases (19 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTA1 23 / 120 cases (19 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TENM1 23 / 120 cases (19 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | XIRP2 23 / 120 cases (19 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGB 22 / 120 cases (18 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 22 / 120 cases (18 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 22 / 120 cases (18 %) · ssm · sclc_ucologne_2015 · largest of 2 cohorts | — | — | Lung Small Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NCAM2 22 / 120 cases (18 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR3 22 / 120 cases (18 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNR 22 / 120 cases (18 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | POTEG 70 / 394 cases (18 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMD 21 / 120 cases (18 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HCN1 21 / 120 cases (18 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCLO 21 / 120 cases (18 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TPTE 68 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD20A1 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CBWD3 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM86B2 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LINC02203 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB3 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4F4 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4M2 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4N4 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RABL2B 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL22A1 20 / 120 cases (17 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 20 / 120 cases (17 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 20 / 120 cases (17 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FMN2 20 / 120 cases (17 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPHKAP 20 / 120 cases (17 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF729 20 / 120 cases (17 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FOXD4L3 65 / 394 cases (16 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A6 62 / 394 cases (16 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACR 60 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB130A 60 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB2 60 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RRP7A 59 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHANK3 58 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WASHC1 58 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHEK2 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNTNAP3B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB105B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |